J Korean Ophthalmol Soc > Volume 52(9); 2011 > Article
Journal of the Korean Ophthalmological Society 2011;52(9):1063-1070.
DOI: https://doi.org/10.3341/jkos.2011.52.9.1063    Published online September 15, 2011.
Posterior Sub-Tenon Triamcinolone Acetonide Injection for Recurrent Diabetic Macular Edema after Repeated Intravitreal Bevacizumab Injections.
Jong Ho Kim, Dong Ho Park, Jae Pil Shin, Si Yeol Kim
1Department of Ophthalmology, Kyungpook National University School of Medicine, Daegu, Korea.
2Nune Eye Hospital, Daegu, Korea. kimsy@knu.ac.kr
반복된 유리체강내 베바시주맙 주입술 후 재발한 당뇨황반부종에 후테논낭하 트리암시놀론 주입술
김종호1⋅박동호1⋅신재필1⋅김시열2
Department of Ophthalmology, Kyungpook National University School of Medicine1, Daegu, Korea Nune Eye Hospital2, Daegu, Korea
Abstract
PURPOSE
To evaluate posterior sub-Tenon injection of triamcinolone acetonide (TA) for recurrent diabetic macular edema (DME) after repeated intravitreal bevacizumab (IVB). METHODS: This is a retrospective interventional case series comprised of 35 eyes (32 patients) with recurrent clinically significant DME after two or more IVB treatments. All patients were administered TA 40 mg injections. Best-corrected visual acuity (BCVA), central macular thickness (CMT), and intraocular pressure (IOP) were reevaluated at months 1, 3, and 6. RESULTS: The baseline OCT showed five eyes with diffuse retinal thickening, 18 eyes with cystoid macular edema, and 12 eyes with serous retinal detachment. Mean BCVA improved at months 1 and 3, and mean CMT decreased at months 1 and 3. However, mean BCVA and CMT at six months was not different from baseline. Each DME pattern showed significant improvements in BCVA and CMT at three months. Mean IOP at months 1, 3, and 6 did not show any significant difference from baseline. No eyes showed complications including cataract progression or endophthalmitis. CONCLUSIONS: Posterior sub-Tenon injection of TA should be considered for patients with recurrent DME after repeated IVB. The studied eyes showed improvements in BCVA and CMT during three months in all of the three patterns of DME.
Key Words: Bevacizumab;Diabetic macular edema;Posterior sub-Tenon injection;Triamcinolone acetonide


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2021 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next